Company News: Otsuka Pharma

Share this article:
The iPad Age is upon us, as Bloomberg reports that Otsuka Pharma is buying 1,300 of the devices for its sales reps in Japan. If it goes well, the company, which co-promotes Abilify with Bristol-Myers Squibb in Europe and the US, might arm its sales forces with the iPad globally. 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions